Radcliffe Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-217	Closed	-$4.38M	–	910
2022 Q3	$4.38M	Buy	217 +21	+11%	+$424K	0.11%	322
2022 Q2	$3.92M	Buy	196 +41	+26%	+$821K	0.09%	385
2022 Q1	$3.1M	Buy	155 +5	+3%	+$100K	0.07%	431
2021 Q4	$2.97M	Buy	+150	New	+$2.97M	0.08%	384